Diabetic Retinopathy (DR): The Silent Threat

Diabetic retinopathy (DR) is a common yet often undiagnosed complication of diabetes mellitus, leading to vision impairment and potential blindness if left untreated. It is a major cause of vision loss among working-age adults worldwide, with its prevalence increasing alongside the global rise in diabetes. DR results from prolonged hyperglycemia, which damages the small blood vessels of the retina, progressing from mild non-proliferative stages to severe proliferative retinopathy. In advanced stages, complications such as retinal hemorrhage and detachment may occur. Because early DR is typically asymptomatic, routine eye screenings are vital for timely detection. Research has significantly advanced DR management. Anti-VEGF injections have proven effective in reducing macular edema and abnormal vessel growth, while laser photocoagulation remains a standard treatment for advanced cases. Emerging diagnostic technologies, including AI-enhanced retinal imaging and OCT, are improving early detection rates. Despite these advances, prevention is key. Maintaining strict glycemic control, managing blood pressure, and adopting healthy lifestyle habits are critical. This article highlights the causes, risk factors, symptoms, and treatment of DR, while emphasizing the importance of early detection and prevention to protect vision and quality of life.